Nuveen, LLC Atea Pharmaceuticals, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 291,091 shares of AVIR stock, worth $861,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
291,091Holding current value
$861,629% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
51.5MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$27 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$22.5 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$14.2 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$14 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$9.89 Million0.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $246M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...